Biotech companies by days to cover
Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.
Immunovant leads the 24 biotech companies ranked by days to cover, at 15.3, ahead of Scholar Rock Holding (13.6) and CRISPR Therapeutics (13.1). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report.
Key facts
- Companies ranked
- 24
- First
- Immunovant15.3
- Median
- 6.4
- Combined market value
- AED 3.07T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Days to cover ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ImmunovantIMVT · Health Care | 15.3 | AED 25.2B | AED 121.83 | 0.12% down | 43% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | 13.6 | AED 21.5B | AED 176.30 | 6.48% up | 14% up | ||
| 3 | CRISPR TherapeuticsCRSP · Health Care | 13.1 | AED 14.3B | AED 147.61 | 0.10% up | 21% down | ||
| 4 | Krystal BiotechKRYS · Health Care | 12.2 | AED 34.3B | AED 1,158.21 | 5.62% up | 46% up | ||
| 5 | ExelixisEXEL · Health Care | 11.7 | AED 61.2B | AED 250.82 | 0.31% down | 63% up | ||
| 6 | CG OncologyCGON · Health Care | 11.0 | AED 26.2B | AED 293.83 | 1.34% up | 85% up | ||
| 7 | ImmunityBioIBRX · Health Care | 10.8 | AED 26.2B | AED 24.61 | 7.03% up | 193% up | ||
| 8 | Kymera TherapeuticsKYMR · Health Care | 10.5 | AED 38B | AED 444.90 | 0.32% down | 87% up | ||
| 9 | Kodiak SciencesKOD · Health Care | 9.3 | AED 23.5B | AED 359.25 | 1.04% up | 396% up | ||
| 10 | Revolution MedicinesRVMD · Health Care | 7.8 | AED 127B | AED 587.00 | 1.76% down | 131% up | ||
| 11 | Halozyme TherapeuticsHALO · Health Care | 6.8 | AED 40.1B | AED 351.86 | 0.18% down | 37% up | ||
| 12 | VaxcytePCVX · Health Care | 6.7 | AED 34B | AED 214.94 | 1.48% down | 22% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | 6.1 | AED 16.9B | AED 104.53 | 0.11% down | 88% up | ||
| 14 | Neurocrine BiosciencesNBIX · Health Care | 5.4 | AED 60.5B | AED 598.17 | 1.84% down | 20% up | ||
| 15 | AmgenAMGN · Health Care | 5.0 | AED 881.9B | AED 1,630.36 | 3.07% down | 34% up | ||
| 16 | RepligenRGEN · Health Care | 4.9 | AED 40.5B | AED 634.20 | 6.47% up | 5% up | ||
| 17 | Twist BioscienceTWST · Health Care | 4.4 | AED 29.1B | AED 427.34 | 3.88% up | 340% up | ||
| 18 | BiogenBIIB · Health Care | 4.0 | AED 136.5B | AED 923.40 | 0.25% up | 49% up | ||
| 19 | argenxARGX · Health Care | 3.4 | AED 217.4B | AED 3,457.12 | 0.66% down | 4% up | ||
| 20 | Gilead SciencesGILD · Health Care | 3.2 | AED 769.8B | AED 620.65 | 0.75% down | 33% up | ||
| 21 | Bio-TechneTECH · Health Care | 2.7 | AED 42B | AED 267.20 | 0.17% up | 26% up | ||
| 22 | BioNTechBNTX · Health Care | 2.2 | AED 75.8B | AED 305.81 | 1.89% down | 16% down | ||
| 23 | ModernaMRNA · Health Care | 1.8 | AED 292.5B | AED 722.79 | 4.84% down | 755% up | ||
| 24 | QiagenQGEN · Health Care | 0.7 | AED 37.6B | AED 182.03 | 0.38% down | 12% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. Days to cover is short interest divided by FINRA's average daily volume for the period, worked out here: FINRA's own printed figure is floored at 1 and capped at 999.99, so it is not used. A company with no average volume reported has no days to cover and is not ranked. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which biotech companies rank first by days to cover?
Immunovant (15.3), Scholar Rock Holding (13.6) and CRISPR Therapeutics (13.1) are the top three of the 24 biotech companies ranked by days to cover as of the 30 Oct 2026 settlement date.
How many biotech companies are in this ranking?
24 are ranked by days to cover.
What are these biotech companies worth together?
The 24 biotech companies ranked by days to cover have a combined market value of AED 3.07T as of the 30 Oct 2026 settlement date.
What does ranking by days to cover measure?
Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Biotech companies by days to cover”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=days-to-cover
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.